The treatment of hypertrophic pyloric stenosis in infancy has provoked many lively discussions and papers during the last 20 years in which the rival claims of medical and surgical treatment have been ably demonstrated. At the same time, increasing interest and skill in diagnosis of the disorders of early infancy have enabled large series of cases to be collected. A review of the literature shows a steadily decreasing mortality rate from this disorder, due not only to improvement in both medical and surgical treatment, but also to the lessened risks of hospital cross infection which have been effected by higher standards of nursing care and hospital accommodation for sick infants.
Still (1924) , using medical treatment, reported a mortality of 32.50o in 234 cases. At the Royal Society of Medicine discussion on this subject in 1941, Paterson quoted six deaths in 95 cases treated by Rammstedt's operation at The Hospital for Sick Children, Great Ormond Street, London, in the year 1939. Levi (1941) treated 100 con-secutive breast-fed infants surgically with no mortality. Dobbs (1941) successfully treated 31 cases with methyl atropine nitrate, although in a further 12 infants medical treatment failed, and surgery became necessary; Mackay (1941) also reported a series treated with this drug. The consensus of opinion at that time was in favour of surgical treatment, largely owing to the short period in hospital necessary and the quick cure in experienced hands, medical treatment being mainly advocated for babies in good condition who were more than 8 weeks of age when first diagnosed.
More recently in America, Ladd, Ware and Pickett (1946) reported a 5 90o mortality rate in 588 surgical cases, and in this country Wood and Smellie (1951) reported 300 cases treated surgically with four deaths. The series of 100 cases, with 11 deaths in 10 years, reported by Ward-McQuaid and Porritt (1950) is a reminder that even with modern skill surgical treatment can carry quite a considerable mortality rate.
In 1951, when this subject was again discussed at the Royal Society of Medicine, Tallerman reported one death in 41 cases treated with methyl atropine nitrate and 26 surgical cases with five deaths, and Denis Browne (1951) reported 407 un- selected cases treated surgically with a 2O0 mortality rate in London between the years 1943 the years and 1945 the years . Davison (1951 quoted a 30o mortality rate in the last 500 cases treated in Newcastle-on-Tyne. Dobbs rightly pointed out that the trend of falling mortality for this disorder corresponded closely with that for the total infant population, suggesting that the same factors might well influence mortality rather than specific improvements in medical and surgical treatment. During this discussion emphasis was properly laid on the importance of early diagnosis, and adequate attention to the minute details of infant care whether medical or surgical treatment was employed.
At Bristol Royal Hospital for Sick Children, in the seven years immediately preceding this investigation, there were 267 cases of pyloric stenosis treated by Rammstedt's operation, 12 of which died, a mortality rate of 4-5°,. In the years 1946-49 this rate had improved. as in 132 cases there were only three deaths, a mortality rate of 2-3%c.
While surgery seems to have been the treatment of choice in most large centres in Britain, medical treatment has continued to evoke interest. In Scandinavia particularly. fresh encouragement was given by Svensgaard (1935) who first advocated the use of methyl atropine nitrate (eumydrin'). Jacoby (1946) reported the successful treatment of 50 consecutive cases with this drug and emphasized the part played in medical treatment by a restricted feeding regime. Todd (1947) reported a series of 112 cases treated medically in Leicester, in which ARCHIVES OF DISEASE IN CHILDHOOD Nyman (1943 Nyman ( : 1944 In view of Malmberg's claim that 'skopyl' is more efficient, quicker and less dangerous than treatment with atropine or 'eumydrin', and that it has greatly reduced the need for surgery, the present investigation was undertaken to evaluate its use in the treatment of infantile hypertrophic pyloric stenosis.
In assessing the claims of any particular line of treatment, certain questions must be answered: (1 In the early cases in this series an attempt was made to continue a normal feeding regime with 'skopyl', 0 1 mg., administered as a tablet dissolved in half a teaspoonful of water by mouth, 15 minutes before feeds, three times daily. (The 'skopyl' drops advocated by Malmberg were not available until later in the trial.) A few babies rapidly ceased vomiting, but experience showed that for the majority a special feeding schedule of the 'ladder' type, as used after Rammstedt's operation, was necessary.
The following is the regime that was eventually adopted:
(1) The stomach is washed out with normal saline.
(2) Five per cent glucose water, or equal parts glucose water and Darrow's solution or saline, is gixen for the first 24 hours, at two-hourly intervals, starting with drachms ii and increasing by drachms ii at alternate feeds.
(3) If vomiting has ceased at 24 hours, halfstrength milk feeds are given alternately with the water feeds. When 2 oz. is reached, the water feeds are omitted and a three-or four-hourly schedule with night feeds, gradually increasing the size of the feeds until 21 oz./lb. daily is taken, calculated on actual body weight.
(4) Human milk or 'frailac' is used for babies who have been breast fed, premature babies, or those in poor condition. For all other babies, half-cream Cow and Gate dried milk was used, as it was thought that the lessened curd formation in the stomach which would result from using a dried milk with reduced protein might be advantageous. Breast feeding is usually resumed on the third or fourth day of treatment, and other milk feeds are brought up to full strength gradually, according to the tolerance of the baby.
(5) Intragastric feeding by milk drip has been employed in a few very ill or feeble babies.
(6) Methyl scopolamine nitrate, 0 1 mg., is given orally, six times daily 15 minutes before feeds, either as a tablet dissolved in a very small quantity of water, or as drops of alcoholic solution.
(7) If vomiting recurs, the stomach is washed out again, methyl scopolamine nitrate is given by subcutaneous injection, and feeding with watery fluids is started again.
The early cases were retained in hospital until 'skopyl' was discontinued, usually four weeks. Subsequently, cases were treated for a longer period and the dosage was more gradually reduced. As soon as normal feeding was well established, vomiting had entirely ceased, and there was evidence of a steady weight gain, the child was discharged home infancy. There was a pair of identical male twins and five other twin infants. The identical twin of one patient was stillborn.
The birth weight distribution of the patients did not differ significantly from that of babies born alive in Bristol during one year of this survey ( Fig. 3A  and 3B ), and included eight premature infants.
Age of Onset. The age at onset of vomiting is shown in Fig. 4 . Ten infants vomited in the first week of life sufficiently seriously for medical advice to be sought; three children were seen by the author before the age of 7 days. In none of these cases could a clinical diagnosis of pyloric stenosis be made at that time. Vomiting lessened during the second week, but started again in the third week. Two of these infants continued to vomit intermittently, but were not referred for consultant opinion until the age of 6 weeks when the clinical diagnosis was obvious. Fifty-seven infants vomited before 21 days, and of the whole series, vomiting started in only nine later than seven weeks. One child began to vomit at 82 days, and was admitted to hospital three days later with classical physical signs. The average age of onset of vomiting was 21 days.
The Feeding. Thirty-nine children were fully breast fed on admission to hospital, and 38 were discharged fully breast fed; one was discharged on some complementary feeding. When breast feeding was resumed it was found necessary to test weigh the babies for a few days as occasionally a very large feed was taken which made the child vomit.
Assessment of the Effects of Treatment Cessation of Vomiting. The speed at which vomiting ceased was considered the most important criterion for judging the effect of treatment. In the early cases of the series, the dosage of methyl scopolamine nitrate was undoubtedly inadequate for most children, and it also seemed necessary to put them on a strict feeding regime for the first few days of treatment. Even so, five early cases on a normal food intake and 'skopyl', 0 1 mg. three times daily, ceased vomiting. Length of Stay in Hospital. As has already been stated it was not a primary object of this trial to reduce the length of stay in hospital to the minimum. Twenty-five children were in hospital for less than 14 days; 27 were discharged in 14 to 21 days, 22 at 21 to 28 days, 14 from 28 to 35 days, and 29 after 35 days. Of the 29 long-stay cases, 18 were treated in the first year of the trial and detained in hospital until the end of drug treatment. Eight of these children had relapses during treatment and were started again. In two cases, gastric drip feeding was used with great benefit. Discharge in one child was delayed by an upper respiratory infection and acute otitis media. Five children were detained in hospital owing to social problems or infection in the home. Other treatment was necessary in four cases, for oesophageal hiatus hernia, cleft lip, and two premature babies too small for discharge.
Duration of Administation of the Drug. During 1949, scarcity of the drug led to early discontinuation in some cases with subsequent relapse. However, treatment for four weeks or less was successful in 10 cases, another three were treated for 28 to 35 days, and four for five to six weeks.
As spontaneous improvement tends to occur in this disorder at about 16 weeks, it was ultimately decided that routine continuation of treatment till about that age would simplify out-patient supervision. The remaining patients were therefore treated for 10 weeks or longer, and the tendency to relapse was eliminated.
Compliations. No symptoms or signs attributable to toxic action of the drug were seen, but the oral dosage of 0 6 mg. daily was never exceeded, and half this dose by subcutaneous injection was well tolerated. The only complications therefore were relapse of vomiting and intercurrent illnes.
Failue to Suess VomitinaI Rehps
The only important complication has been inadequate control or relapse of vomiting after cessation for some days. This occurred almost entirely in the first cases treated, and subsequent experience suggests that the dose of 'skopyl' was too small, and insufficient care was taken in regulating the food intake. In more recent cases, if the child was severely dehydrated or much below birth weight, treatment has been begun with subcutaneous injections of methyl scopolamine nitrate, 0 05 mg. six times daily.
A recent case of a severely ill baby who was succsfuilly treated demonstrates this point.
J.B. weighed 5 lb. on admission at 4 weeks old, having lost 2 lb. in weight since birth and with two weeks' history of vomiting. He was dehydrated, very lethargic, with deep jaundice and severe oral thrush. Typical physical signs were present. Subcutaneous fluid was administered to combat dehydration, and 'skopyl' was given by subcutaneous injection of 0-05 mg. six times daily.
Vomiting ceased completely and an uninterrupted recovery followed. Frailac feeding was used.
Eight cases in the first year relapsed within a week or two of stopping treatment, but were successfully treated again. In the second year, one baby relapsed who had only received treatment for five weeks. With longer periods of treatment no relapses occurred.
Itercurrent Infection. Two children developed upper respiratory infection in hospital, one was complicated by slight secondary diarrhoea and the other by otitis media. One infant, nursed in an 'open' mixed children's ward, developed gastroenteritis which responded fairly rapidly to treatment.
Failures
The 24th case in this series responded inadequately after prolonged trial and was treated surgically.
M.S., aged 5 weeks, started vomiting at 2 weeks of age. The birth weight was 7 lb. 10 oz. and admission weight 6 lb. 4 oz. Moderate dehydration was corrected with subcutaneous fluid. 'Skopyl' was given by mouth, 0-1 mg. three times daily, and subsequently by subcutaneous injection. Vomiting did not cease entirely although it lessened in amount, but, as there was no weight gain, on the 19th day it was decided to perform a Rammstedt's operation, which was followed by uninterrupted recovery.
One patient died, the tenth in the senes. J.L. was a first-born male child (birth weight 9 lb. 1 oz.). He was not admitted for 10 days after the onset of vomiting and his weight had by then fallen to 8 lb. 7 oz. There was moderate dehydration, severe thrush, purulent conjunctivitis and rhinitis. Treatment was started with 'skopyl', 0-I mg. orally three times daily, but this dose was subsequently doubled. Intravenous fluid, 0 43% dexose with 0-18% saline, was used to overcome dehydration, and human milk feeds were given.
There was initial improvement, but the striking and unusual feature of the case was severe anorexia, necessitating tube feeding. 
Discussion
The present series of cases is the largest yet reported of the use of methyl scopolamine nitrate for the treatment of infantile hypertrophic pyloric stenosis. The cases were unselected and included children throughout the normal distribution of birth weights, with all degrees of severity of the disease, some being severely dehydrated. With the exception of two infants, all responded to the treatment, symptoms were relieved and weight gain was satisfactorily re-established.
Lindberg (1946) claimed that since the introduction of this drug the number of cases requiring surgical intervention had been reduced, and the very low toxicity of 'skopyl' was also notable. The present series entirely bears out the Scandinavian experience that most cases of this disease will respond adequately and quickly to treatment, and no toxic symptoms or signs were found in the dosage used.-Although the importance of adequate dosage was borne out in the treatment of our early cases, Laursen (1952) reported two deaths in babies attributable to a toxic action of this drug, but his dosage was in excess of that used in this series.
Other accounts of medical treatment using methyl atropine nitrate laid down specific criteria for selecting cases. Jacoby (1946) gave as his indications for surgery in preference to drug treatment the early onset of vomiting and severe dehydration. Todd (1947) suggested as criteria for operation (1) the inefficiency of medical treatment after a trial of seven days, (2) gross dehydration and (3) a birth weight below 61 lb.
If these criteria are applied to the present series of patients, it is seen that 65% began to vomit before the age of 28 days, but the response of these cases was not significantly different from the older children as judged by rate of cessation of vomiting and start of weight gain. The introduction of hyalase has so aided absorption of fluids given subcutaneously that dehydration can now be much more easily controlled with repeated or prolonged subcutaneous infusion, thus obviating the technical problems raised by the necessity for intravenous infusions. In this series, dehydration was not found to be a contraindication to medical treatment, and of 34 children who were considered to need parenteral fluid, only six were given intravenous infusions. (3) Eight babies in this series were premature according to birth weight (see Table 3 ), and the average age of onset of vomiting was 35*8 days. The history of the progress of these children is similar to that noted by Henderson et al. (1952) , but in the present very small series the average age of onset was later than in the full-term infants. All these children made a rapid and uneventful response to treatment, and 15 other children with birth weights of 61 lb. or less did not present any particular difficulties.
It was thought that length of history might give some indication as to the severity of the disease and likelihood of response to treatment (Fig. 5 ). It will be seen that in all groups of cases the majority of patients responded quickly to treatment, but of the 50 babies who were treated in less than 10 days from the onset of vomiting, seven (14%) still had some vomiting after five days of treatment. Five of the remaining 67 infants (7%) vomited after five days. This difference is not significant (standard error=4-5). 
Smwmry
The literature on the medical and surgical treatment of hypertrophic pyloric stenosis of infancy during the last 20 years is reviewed.
Results of treatment of 117 unselected cases with methyl scopolamine nitrate are presented. One child required operation after a trial period of medical treatment. There was one death (a mortality rate of 0 800).
Methyl scopolamine nitrate can be administered by mouth or by subcutaneous injection and no toxic effects were observed in the dosage used.
Response to treatment was usually rapid. Sixtyfour per cent of infants ceased vomiting immediately, and 80%' in the first 48 hours.
The factors of birth weight, length of history, or presence of dehydration did not seem to bear any relationship to rapidity of response to treatment. Therefore no particular criteria are suggested as contraindications.
A strict regime of feeding with a reduced fluid intake at the start is essential.
The period in hospital can probably be reduced to less than four weeks and less than 14 days in most cases.
The importance of proper accommodation for nursing these patients in isolation and the necessity for an experienced nursing staff are stressed.
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